R256918
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for R256918, covering 2013-01-24 to 2014-07-14. Get the full timeline:
Most recent: Clinical Trial Update: A Study of the Safety and Effectiveness of a R256918 in Patients With Type 2 Diabetes [Phase 2]